232 filings
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
20 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
HEPA
Hepion Pharmaceuticals Inc
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
ndf7srcu1ff ehewkze
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
8-K
beey15zj2b
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
eup28g3ltw tktee7y
6 Sep 23
Departure of Directors or Certain Officers
4:40pm
8-K
2p7zhs9v2x1bqtne0mj
24 Jul 23
Regulation FD Disclosure
4:04pm
8-K
artu46l3hy3srns
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
9wi21
22 Jun 23
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
lyxpya95js11a6gjsneb
22 May 23
Regulation FD Disclosure
1:05pm
8-K
hw4xl6oy7qw 03h
10 May 23
Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split
5:17pm
8-K
o4xppbkp 9kp3qs
15 Dec 22
Submission of Matters to a Vote of Security Holders
8:25pm
8-K
kpgcb3cli
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
97mvqqq1 lqrpa5uq1kr
17 Oct 22
Regulation FD Disclosure
5:13pm
8-K
9p5g4d0crl9rc57o6u84
5 Aug 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
ep3v1rxeo58edggyvvh8
28 Jun 22
Departure of Directors or Certain Officers
9:46am
8-K
z7eq6lmu
27 Jun 22
Submission of Matters to a Vote of Security Holders
6:05am
8-K
uz291v27 yzz
6 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm